SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-014971
Filing Date
2019-08-08
Accepted
2019-08-08 16:48:35
Documents
14
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k080819_nektartherap.htm   iXBRL 8-K 38325
2 PRESS RELEASE TITLED NEKTAR THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE SECON f8k080819ex99-1_nektartherap.htm EX-99.1 102729
6 GRAPHIC image_001.jpg GRAPHIC 2030
  Complete submission text file 0001213900-19-014971.txt   332937

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nktr-20190808.xsd EX-101.SCH 3171
4 XBRL LABEL FILE nktr-20190808_lab.xml EX-101.LAB 33466
5 XBRL PRESENTATION FILE nktr-20190808_pre.xml EX-101.PRE 21945
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k080819_nektartherap_htm.xml XML 3627
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 191010244
SIC: 2834 Pharmaceutical Preparations